AAAAAA
Results:
1-8
|
Results: 8
Authors:
Waters, CH
Citation: Ch. Waters, Advances in managing Parkinson's disease, HOSP PRACT, 36(6), 2001, pp. 27
Authors:
Weiner, WJ
Factor, SA
Jankovic, J
Hauser, RA
Tetrud, JW
Waters, CH
Shulman, LM
Glassman, PM
Beck, B
Paume, D
Doyle, C
Citation: Wj. Weiner et al., The long-term safety and efficacy of pramipexole in advanced Parkinson's disease, PARKINS R D, 7(2), 2001, pp. 115-120
Authors:
Hutton, JT
Metman, LV
Chase, TN
Juncos, JL
Koller, WC
Pahwa, R
LeWitt, PA
Samii, A
Tsui, JKC
Calne, DB
Waters, CH
Calabrese, VP
Bennett, JP
Barrett, R
Morris, JL
Citation: Jt. Hutton et al., Transdermal dopaminergic D-2 receptor agonist therapy in parkinson's disease with n-0923 TDS: A double-blind, placebo-controlled study, MOVEMENT D, 16(3), 2001, pp. 459-463
Authors:
Breitenstein, C
Van Lancker, D
Daum, I
Waters, CH
Citation: C. Breitenstein et al., Impaired perception of vocal emotions in Parkinson's disease: Influence ofspeech time processing and executive functioning, BRAIN COGN, 45(2), 2001, pp. 277-314
Authors:
DeStefano, AL
Golbe, LI
Mark, MH
Lazzarini, AM
Maher, NE
Saint-Hilaire, M
Feldman, RG
Guttman, M
Watts, RL
Suchowersky, O
Lafontaine, AL
Labelle, N
Lew, MF
Waters, CH
Growdon, JH
Singer, C
Currie, LJ
Wooten, GF
Vieregge, P
Pramstaller, PP
Klein, C
Hubble, JP
Stacy, M
Montgomery, E
MacDonald, ME
Gusella, JF
Myers, RH
Citation: Al. Destefano et al., Genome-wide scan for Parkinson's disease: The GenePD study, NEUROLOGY, 57(6), 2001, pp. 1124-1126
Authors:
Lambert, D
Waters, CH
Citation: D. Lambert et Ch. Waters, Comparative tolerability of the newer generation antiparkinsonian agents, DRUG AGING, 16(1), 2000, pp. 55-65
Authors:
Frucht, S
Fahn, S
Shannon, KM
Waters, CH
Citation: S. Frucht et al., A 32-year-old man with progressive spasticity and Parkinsonism, MOVEMENT D, 14(2), 1999, pp. 350-357
Authors:
Waters, CH
Citation: Ch. Waters, Therapeutics of Parkinson's disease, PARKINSON'S DISEASE: THE TREATMENT OPTIONS, 1999, pp. 79-91
Risultati:
1-8
|